Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom-and-bust cycle? By Madison Muller and Brad Stone

Cyberbullying Group 764 Torments Teenagers as Blood Sport
28:19

Caveat Injector
36:42

How a Tiny British Island Fell Into an International Gambling Scandal
25:31